Skip to main content
Terug
Watch Compare

Fortress Biotech, Inc.

Datakwaliteit: 100%
Ook genoteerd als FBIOP NASDAQ
FBIO
NASDAQ Manufacturing Chemicals
€ 2,35
▼ € 0,05 (-2,08%)
Marktkapitalisatie: 76,80 M
Prijs
€ 2,39
Marktkapitalisatie
76,80 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—

Quick Summary

Belangrijkste Punten

Revenue declined -2,07% annually over 5 years
ROE of 13,66% — decent returns on equity
Negative free cash flow of -65,78 M
P/E of 11,27 — trading at a low valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 11,76%

Groei

Revenue Growth (5Y)
-2,07%
Onder sectorgemiddelde (1,82%)
Revenue (1Y)9,69%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
13,66%
Boven sectorgemiddelde (-54,01%)
ROIC-48,30%
Net Margin10,77%
Op. Margin-111,00%

Veiligheid

Debt / Equity
0,86
Boven sectorgemiddelde (0,30)
Current Ratio2,19
Interest Coverage-6,95

Waardering

PE (TTM|NTM|2027)
11,27 | 4,65 | 4,73
Boven sectorgemiddelde (-1,49)
P/B Ratio1,37
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1385 peers)
Metriek Aandeel Sector Mediaan
P/E 11,3 -1,5
P/B 1,4 1,6
ROE % 13,7 -54,0
Net Margin % 10,8 -41,5
Rev Growth 5Y % -2,1 1,8
D/E 0,9 0,3

Koersdoel Analisten

2 analisten
Buy
Huidig
€ 2,35
+357.4%
Koersdoel
€ 10,75
€ 4,50
€ 10,75
€ 17,00
Vooruitzicht
Forward K/W 4,65
Forward WPA € 0,51
Omzet Sch. 135,31 M

Winstschattingen

Periode WPA Sch. Omzet Sch. Analisten
FY2027 € 0,51
-€ 0,50 – € 1,51
 135,31 M 2
FY2026 -€ 0,70
-€ 0,70 – -€ 0,70
 81,74 M 1

Winstverassingen

Laatste 4 kwartalen
Kwartaal Geschat WPA Werkelijk WPA Verrassing
Q42025 € 0,11 -€ 0,21 -290,9%
Q32025 -€ 0,63 € 0,11 +117,6%
Q22025 -€ 0,31 -€ 0,51 -65,3%
Q12025 -€ 0,44 -€ 0,48 -9,1%

ETFs Holding This Stock

BRUSX BRUSX
0,74% weight
DLHAX DLHAX
0,00% weight
DLRHX DLRHX
0,00% weight
DLHIX DLHIX
0,00% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) 9,69% Revenue Growth (3Y) -13,48%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) -2,07% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 63,26 M Net Income (TTM) 6,82 M
ROE 13,66% ROA 3,99%
Gross Margin N/A Operating Margin -111,00%
Net Margin 10,77% Free Cash Flow (TTM) -65,78 M
ROIC -48,30% FCF Growth (3Y) N/A
Safety
Debt / Equity 0,86 Current Ratio 2,19
Interest Coverage -6,95 Asset Turnover 0,37
Working Capital 64,44 M Tangible Book Value 27,19 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 11,27 Forward P/E 4,65
P/B Ratio 1,37 P/S Ratio 1,21
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S 0,57 Fwd Earnings Yield 21,51%
FCF Yield -85,64%
Market Cap 76,80 M Enterprise Value 38,36 M
Per Share
EPS (Diluted TTM) -0,07 Revenue / Share 1,96
FCF / Share -2,04 OCF / Share -2,04
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion -965,18%
SBC-Adj. FCF -98,63 M Growth Momentum 11,76

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 63,26 M 57,68 M 84,51 M 75,74 M 68,79 M
Net Income 6,82 M -46,00 M -60,64 M -86,58 M -64,70 M
EPS (Diluted) -0,07 -2,69 -8,47 -0,97 —
Gross Profit — — — — —
Operating Income -70,22 M -110,38 M -142,34 M -203,56 M -188,54 M
EBITDA — — — — —
R&D Expenses — — 106,07 M 134,88 M 128,87 M
SG&A Expenses 96,40 M 87,73 M 94,12 M 113,66 M 86,84 M
D&A — — — — —
Interest Expense 10,11 M 13,53 M 15,32 M 12,48 M 15,31 M
Income Tax -620.000,0 312.000,0 521.000,0 449.000,0 473.000,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 185,55 M 144,22 M 167,53 M 294,30 M 396,50 M
Total Liabilities 123,37 M 145,87 M 165,94 M 244,28 M 170,63 M
Shareholders' Equity 49,87 M 22,74 M 22,54 M 41,72 M 108,67 M
Total Debt 52,42 M 57,96 M 60,86 M 91,73 M 42,94 M
Cash & Equivalents 79,38 M 57,26 M 80,93 M 178,27 M 305,74 M
Current Assets 123,84 M 90,37 M 117,02 M 230,43 M 346,46 M
Current Liabilities 49,74 M 71,40 M 84,91 M 127,72 M 101,04 M